Author: Dr. David Lowemann

Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice

Ting Cao, Xiaojuan Zhou, Xianjie Zheng, Yue Cui, Joe Z. Tsien, Chunxia Li, Huimin Wang Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a […]

Published on May 15, 2018

Low Plasma Leptin and High Soluble Leptin Receptor Levels Are Associated With Mild Cognitive Impairment in Type 2 Diabetic Patients

Han Yin, Sai Tian, Rong Huang, Rongrong Cai, Dan Guo, Hongyan Lin, Jiaqi Wang, Shaohua Wang Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With […]

Published on May 15, 2018

Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases

Syed Zahid Ali Shah, Deming Zhao, Tariq Hussain, Naveed Sabir, Lifeng Yang Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in […]

Published on May 15, 2018